Published in BMC Biol on May 21, 2013
A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility. Cell (2016) 3.47
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut (2015) 1.76
Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. Bioessays (2014) 1.64
The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis (2015) 1.33
Gut microbiota, metabolites and host immunity. Nat Rev Immunol (2016) 1.22
Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health. Front Microbiol (2016) 1.20
Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii. MBio (2015) 1.00
Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol (2015) 0.98
Functional metabolic map of Faecalibacterium prausnitzii, a beneficial human gut microbe. J Bacteriol (2014) 0.97
Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut Microbes (2013) 0.97
Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii. Gut Microbes (2014) 0.96
Host-microbe interactions shaping the gastrointestinal environment. Trends Immunol (2014) 0.95
Genome-Wide Association Studies of the Human Gut Microbiota. PLoS One (2015) 0.93
The role of metagenomics in understanding the human microbiome in health and disease. Virulence (2014) 0.93
Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture. PLoS One (2014) 0.93
Succession and replacement of bacterial populations in the caecum of egg laying hens over their whole life. PLoS One (2014) 0.89
Chicken Caecal Microbiome Modifications Induced by Campylobacter jejuni Colonization and by a Non-Antibiotic Feed Additive. PLoS One (2015) 0.88
Dysbiotic events in gut microbiota: impact on human health. Nutrients (2014) 0.87
Genome-scale metabolic reconstructions of Bifidobacterium adolescentis L2-32 and Faecalibacterium prausnitzii A2-165 and their interaction. BMC Syst Biol (2014) 0.87
Impact of stressor exposure on the interplay between commensal microbiota and host inflammation. Gut Microbes (2014) 0.87
Temperate phages acquire DNA from defective prophages by relaxed homologous recombination: the role of Rad52-like recombinases. PLoS Genet (2014) 0.86
Pyrosequencing 16S rRNA genes of bacteria associated with wild tiger mosquito Aedes albopictus: a pilot study. Front Cell Infect Microbiol (2014) 0.85
The Enteric Two-Step: nutritional strategies of bacterial pathogens within the gut. Cell Microbiol (2014) 0.85
Early colonizing Escherichia coli elicits remodeling of rat colonic epithelium shifting toward a new homeostatic state. ISME J (2014) 0.85
Virulent Shigella flexneri affects secretion, expression, and glycosylation of gel-forming mucins in mucus-producing cells. Infect Immun (2013) 0.85
A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe. Microb Cell Fact (2015) 0.85
Understanding how commensal obligate anaerobic bacteria regulate immune functions in the large intestine. Nutrients (2014) 0.83
Immunological aspects of intestinal mucus and mucins. Nat Rev Immunol (2016) 0.83
Phytonutrient diet supplementation promotes beneficial Clostridia species and intestinal mucus secretion resulting in protection against enteric infection. Sci Rep (2015) 0.82
Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases. Front Microbiol (2015) 0.82
Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease. Front Immunol (2016) 0.82
Anti-biofilm Activity as a Health Issue. Front Microbiol (2016) 0.81
Functions of innate immune cells and commensal bacteria in gut homeostasis. J Biochem (2015) 0.81
Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice. ISME J (2015) 0.80
Isolation and characterization of Faecalibacterium prausnitzii from calves and piglets. PLoS One (2014) 0.80
Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models. Sci Rep (2016) 0.79
Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection. BMC Med (2016) 0.79
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J (2017) 0.78
Mucin-Microbiota Interaction During Postnatal Maturation of the Intestinal Ecosystem: Clinical Implications. Dig Dis Sci (2016) 0.78
Influences of the colonic microbiome on the mucous gel layer in ulcerative colitis. Gut Microbes (2014) 0.78
Mucosa-Associated Faecalibacterium prausnitzii Phylotype Richness Is Reduced in Patients with Inflammatory Bowel Disease. Appl Environ Microbiol (2015) 0.78
Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic. Front Microbiol (2017) 0.78
Dietary Mannan Oligosaccharides: Counteracting the Side Effects of Soybean Meal Oil Inclusion on European Sea Bass (Dicentrarchus labrax) Gut Health and Skin Mucosa Mucus Production? Front Immunol (2015) 0.76
Enterococcus durans EP1 a Promising Anti-inflammatory Probiotic Able to Stimulate sIgA and to Increase Faecalibacterium prausnitzii Abundance. Front Immunol (2017) 0.75
Homeostasis of the Gut Barrier and Potential Biomarkers. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Impacts of resistant starch and wheat bran consumption on enteric inflammation in relation to colonic bacterial community structures and short-chain fatty acid concentrations in mice. Gut Pathog (2016) 0.75
Altered intestinal microbiota in patients with chronic pancreatitis: implications in diabetes and metabolic abnormalities. Sci Rep (2017) 0.75
Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice. Front Microbiol (2016) 0.75
Gnotobiotic Rodents: An In Vivo Model for the Study of Microbe-Microbe Interactions. Front Microbiol (2016) 0.75
Oral administration of a select mixture of Bacillus probiotics affects the gut microbiota and goblet cell function in newly weaned MUC4 resistant pigs following Escherichia coli challenge. Appl Environ Microbiol (2016) 0.75
Vitamin B12 Uptake by the Gut Commensal Bacteria Bacteroides thetaiotaomicron Limits the Production of Shiga Toxin by Enterohemorrhagic Escherichia coli. Toxins (Basel) (2016) 0.75
Intestinal barrier analysis by assessment of mucins, tight junctions, and α-defensins in healthy C57BL/6J and BALB/cJ mice. Tissue Barriers (2016) 0.75
Bacteria isolated from lung modulate asthma susceptibility in mice. ISME J (2017) 0.75
Microbiota Is Involved in Post-resection Adaptation in Humans with Short Bowel Syndrome. Front Physiol (2017) 0.75
Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System. Cell Metab (2017) 0.75
Towards an Integrative Understanding of Diet-Host-Gut Microbiome Interactions. Front Immunol (2017) 0.75
Interactions of Intestinal Bacteria with Components of the Intestinal Mucus. Front Cell Infect Microbiol (2017) 0.75
Reciprocal Prioritization to Dietary Glycans by Gut Bacteria in a Competitive Environment Promotes Stable Coexistence. MBio (2017) 0.75
Detrimental Impact of Microbiota-Accessible Carbohydrate-Deprived Diet on Gut and Immune Homeostasis: An Overview. Front Immunol (2017) 0.75
Leaky Gut As a Danger Signal for Autoimmune Diseases. Front Immunol (2017) 0.75
The effect of age on the intestinal mucus thickness, microbiota composition and immunity in relation to sex in mice. PLoS One (2017) 0.75
Microbial Metabolic Networks at the Mucus Layer Lead to Diet-Independent Butyrate and Vitamin B12 Production by Intestinal Symbionts. MBio (2017) 0.75
MicroRNAs-Based Inter-Domain Communication between the Host and Members of the Gut Microbiome. Front Microbiol (2017) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Diversity of the human intestinal microbial flora. Science (2005) 49.64
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
Evolution of mammals and their gut microbes. Science (2008) 21.40
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell (2005) 15.46
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res (2007) 13.08
A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science (2003) 12.57
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut (2005) 10.95
Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science (2005) 9.08
Mucosal flora in inflammatory bowel disease. Gastroenterology (2002) 8.42
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A (2008) 7.43
Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology (2006) 6.55
Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A (2008) 6.42
A model of host-microbial interactions in an open mammalian ecosystem. Science (1996) 5.85
Towards the human intestinal microbiota phylogenetic core. Environ Microbiol (2009) 5.72
Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe (2008) 5.39
The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development (2002) 5.09
Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis (2009) 4.72
Microbes in gastrointestinal health and disease. Gastroenterology (2008) 4.65
Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci U S A (2009) 4.09
How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol (2012) 3.65
Human symbionts use a host-like pathway for surface fucosylation. Science (2005) 3.14
Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep (2010) 2.93
Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One (2011) 2.84
Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One (2010) 2.82
Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology (2011) 2.79
p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci U S A (1998) 2.65
Microbial degradation of complex carbohydrates in the gut. Gut Microbes (2012) 2.51
Functional genomic and metabolic studies of the adaptations of a prominent adult human gut symbiont, Bacteroides thetaiotaomicron, to the suckling period. J Biol Chem (2006) 2.43
Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol (2002) 2.35
Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae. Mol Microbiol (2002) 2.30
Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther (2006) 1.97
Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis. Clin Sci (Lond) (1992) 1.88
Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol (2011) 1.55
Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol (2008) 1.45
Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J (2012) 1.40
Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations. J Cell Sci (1993) 1.40
Role of glycan synthesis in colonization of the mammalian gut by the bacterial symbiont Bacteroides fragilis. Proc Natl Acad Sci U S A (2008) 1.37
Sulfatases and a radical S-adenosyl-L-methionine (AdoMet) enzyme are key for mucosal foraging and fitness of the prominent human gut symbiont, Bacteroides thetaiotaomicron. J Biol Chem (2011) 1.34
Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. Differentiation (2008) 1.30
The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem J (2009) 1.25
Structure and carbohydrate analysis of the exopolysaccharide capsule of Pseudomonas putida G7. Environ Microbiol (2001) 1.12
Histochemical, lectin-histochemical and morphometrical characteristics of intestinal goblet cells of germfree and conventional mice. Exp Anim (1996) 1.11
Krüppel-like factor 4 is transactivated by butyrate in colon cancer cells. J Nutr (2004) 1.10
The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T. Biochem Biophys Res Commun (2007) 1.08
Drastic changes in fecal and mucosa-associated microbiota in adult patients with short bowel syndrome. Biochimie (2010) 1.08
Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. Am J Physiol Gastrointest Liver Physiol (2004) 1.03
Microbiota matures colonic epithelium through a coordinated induction of cell cycle-related proteins in gnotobiotic rat. Am J Physiol Gastrointest Liver Physiol (2010) 1.01
Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon. Physiol Res (2008) 0.99
Effect of germfree state on the capacities of isolated rat colonocytes to metabolize n-butyrate, glucose, and glutamine. Gastroenterology (1995) 0.98
Roles of capsule and lipopolysaccharide O antigen in interactions of human monocyte-derived dendritic cells and Klebsiella pneumoniae. Infect Immun (2009) 0.95
Primocolonization is associated with colonic epithelial maturation during conventionalization. FASEB J (2012) 0.95
Multifaceted transcriptional regulation of the murine intestinal mucus layer by endogenous microbiota. Genomics (2007) 0.93
Increased induction of apoptosis by Propionibacterium freudenreichii TL133 in colonic mucosal crypts of human microbiota-associated rats treated with 1,2-dimethylhydrazine. Br J Nutr (2008) 0.92
Almost all human gastric mucin O-glycans harbor blood group A, B or H antigens and are potential binding sites for Helicobacter pylori. Glycobiology (2012) 0.92
Sulfation of colonic mucins by N-acetylglucosamine 6-O-sulfotransferase-2 and its protective function in experimental colitis in mice. J Biol Chem (2009) 0.91
Impact of the metabolic activity of Streptococcus thermophilus on the colon epithelium of gnotobiotic rats. J Biol Chem (2011) 0.88
Carbohydrate metabolism is essential for the colonization of Streptococcus thermophilus in the digestive tract of gnotobiotic rats. PLoS One (2011) 0.88
Butyrate regulation of glycosylation-related gene expression: evidence for galectin-1 upregulation in human intestinal epithelial goblet cells. Biochem Biophys Res Commun (2004) 0.86
Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation. Oncogene (2003) 0.85
Growth advantage of Streptococcus thermophilus over Lactobacillus bulgaricus in vitro and in the gastrointestinal tract of gnotobiotic rats. Benef Microbes (2012) 0.82
Indigenous microbes and their soluble factors differentially modulate intestinal glycosylation steps in vivo. Use of a "lectin assay" to survey in vivo glycosylation changes. Histochem Cell Biol (2005) 0.80
Behavior of lactobacilli isolated from fermented slurry (ben-saalga) in gnotobiotic rats. PLoS One (2013) 0.80
Effect of oxidoreduction potential on aroma biosynthesis by lactic acid bacteria in nonfat yogurt. J Dairy Sci (2011) 0.78
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity (2009) 8.95
Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One (2011) 2.84
The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models. Inflamm Bowel Dis (2014) 2.46
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med (2011) 2.25
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut (2012) 2.17
Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol (2009) 1.89
Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci Transl Med (2012) 1.73
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut (2012) 1.64
Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am J Pathol (2006) 1.61
Prediction of surface exposed proteins in Streptococcus pyogenes, with a potential application to other Gram-positive bacteria. Proteomics (2009) 1.58
Heterologous protein production and delivery systems for Lactococcus lactis. Genet Mol Res (2003) 1.48
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines. Microb Cell Fact (2011) 1.45
Protein secretion in Lactococcus lactis : an efficient way to increase the overall heterologous protein production. Microb Cell Fact (2005) 1.45
A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J Immunol (2005) 1.43
Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines. Carcinogenesis (2004) 1.42
Growth hormone treatment and fat redistribution in children born small for gestational age. J Pediatr (2007) 1.39
Survival and metabolic activity of selected strains of Propionibacterium freudenreichii in the gastrointestinal tract of human microbiota-associated rats. Br J Nutr (2007) 1.38
Impact of lactobacilli on orally acquired listeriosis. Proc Natl Acad Sci U S A (2012) 1.38
Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis. Appl Environ Microbiol (2002) 1.33
Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells. Int J Cancer (2007) 1.30
Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems. Protein Expr Purif (2011) 1.26
Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice. Microb Cell Fact (2007) 1.25
Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study. J Clin Endocrinol Metab (2012) 1.22
Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect Immun (2003) 1.21
Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells. Appl Environ Microbiol (2009) 1.19
Characterization of O-acetylation of N-acetylglucosamine: a novel structural variation of bacterial peptidoglycan. J Biol Chem (2011) 1.15
The flagellar sigma factor FliA regulates adhesion and invasion of Crohn disease-associated Escherichia coli via a cyclic dimeric GMP-dependent pathway. J Biol Chem (2007) 1.15
Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease. Microb Cell Fact (2013) 1.14
Internalin-expressing Lactococcus lactis is able to invade small intestine of guinea pigs and deliver DNA into mammalian epithelial cells. Microbes Infect (2005) 1.13
An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J Med Microbiol (2004) 1.13
Metabolism of sinigrin (2-propenyl glucosinolate) by the human colonic microflora in a dynamic in vitro large-intestinal model. Carcinogenesis (2002) 1.11
Thiostrepton tryptophan methyltransferase expands the chemistry of radical SAM enzymes. Nat Chem Biol (2012) 1.10
Beneficial effects of exclusive enteral nutrition in Crohn's disease are not mediated by Faecalibacterium prausnitzii. Inflamm Bowel Dis (2014) 1.08
Drastic changes in fecal and mucosa-associated microbiota in adult patients with short bowel syndrome. Biochimie (2010) 1.08
Intestinal microflora and digestive toxicity of irinotecan in mice. Clin Cancer Res (2006) 1.07
Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans. Appl Environ Microbiol (2005) 1.06
Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells. Appl Environ Microbiol (2006) 1.05
Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine (2007) 1.04
Oxidative stress in Lactococcus lactis. Genet Mol Res (2003) 1.03
Nuclease A (Gbs0661), an extracellular nuclease of Streptococcus agalactiae, attacks the neutrophil extracellular traps and is needed for full virulence. Mol Microbiol (2013) 1.03
Lactobacilli as multifaceted probiotics with poorly disclosed molecular mechanisms. Int J Food Microbiol (2010) 1.03
Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int J Food Microbiol (2010) 1.01
Controlled intra- or extracellular production of staphylococcal nuclease and ovine omega interferon in Lactococcus lactis. FEMS Microbiol Lett (2003) 1.01
Microbiota matures colonic epithelium through a coordinated induction of cell cycle-related proteins in gnotobiotic rat. Am J Physiol Gastrointest Liver Physiol (2010) 1.01
Anti-inflammatory properties of dairy lactobacilli. Inflamm Bowel Dis (2011) 1.00
Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii. MBio (2015) 1.00
Impact of probiotics on risk factors for cardiovascular diseases. A review. Crit Rev Food Sci Nutr (2014) 0.99
A new plasmid vector for DNA delivery using lactococci. Genet Vaccines Ther (2009) 0.99
Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein. FEMS Microbiol Lett (2003) 0.99
Engineering lactococci and lactobacilli for human health. Curr Opin Microbiol (2013) 0.96
Production of a heterologous nonheme catalase by Lactobacillus casei: an efficient tool for removal of H2O2 and protection of Lactobacillus bulgaricus from oxidative stress in milk. Appl Environ Microbiol (2006) 0.96
Efficient production and secretion of bovine beta-lactoglobulin by Lactobacillus casei. Microb Cell Fact (2007) 0.96
Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update. FEMS Microbiol Lett (2013) 0.95
Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli. J Drug Target (2005) 0.95
Primocolonization is associated with colonic epithelial maturation during conventionalization. FASEB J (2012) 0.95
Identification of one novel candidate probiotic Lactobacillus plantarum strain active against influenza virus infection in mice by a large-scale screening. Appl Environ Microbiol (2012) 0.95
Faecal D/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome. PLoS One (2013) 0.95
Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn's disease in mice. J Biotechnol (2010) 0.94
Morphological adaptation with preserved proliferation/transporter content in the colon of patients with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2009) 0.93
Comparative capacities of the pig colon and duodenum for luminal iron absorption. Can J Physiol Pharmacol (2007) 0.93
O-glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines. Glycobiology (2009) 0.93
Clostridium difficile and Clostridium perfringens species detected in infant faecal microbiota using 16S rRNA targeted probes. J Microbiol Methods (2006) 0.92
Eubacterium limosum activates isoxanthohumol from hops (Humulus lupulus L.) into the potent phytoestrogen 8-prenylnaringenin in vitro and in rat intestine. J Nutr (2008) 0.92
Increased induction of apoptosis by Propionibacterium freudenreichii TL133 in colonic mucosal crypts of human microbiota-associated rats treated with 1,2-dimethylhydrazine. Br J Nutr (2008) 0.92
Almost all human gastric mucin O-glycans harbor blood group A, B or H antigens and are potential binding sites for Helicobacter pylori. Glycobiology (2012) 0.92
Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae. Microbiol Immunol (2008) 0.91
A probiotic Lactobacillus strain can acquire vancomycin resistance during digestive transit in mice. J Mol Microbiol Biotechnol (2008) 0.91
Lactobacillaceae and cell adhesion: genomic and functional screening. PLoS One (2012) 0.90
MicroRNA in the ovine mammary gland during early pregnancy: spatial and temporal expression of miR-21, miR-205, and miR-200. Physiol Genomics (2012) 0.90
Carbohydrate utilization by enterohaemorrhagic Escherichia coli O157:H7 in bovine intestinal content. Environ Microbiol (2012) 0.89
Expression of mitochondrial HMGCoA synthase and glutaminase in the colonic mucosa is modulated by bacterial species. Eur J Biochem (2004) 0.89
A xylose-inducible expression system for Lactococcus lactis. FEMS Microbiol Lett (2004) 0.88
Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice. Clin Vaccine Immunol (2007) 0.88
Impact of the metabolic activity of Streptococcus thermophilus on the colon epithelium of gnotobiotic rats. J Biol Chem (2011) 0.88